
A new, not-for-profit coalition has launched with a mission to tackle antimicrobial resistance (AMR) and what it sees as the …

Red Door Unlimited has appointed two consultants in Jock McEwan who joins as digital senior account director, and Gill Dunn …

The Myeloma UK Clinical Trial Network (CTN) has published data from its first trial marking a major milestone for the …

Merck’s diabetes drug Januvia has been given a boost following worries over side effects for patients after a trial revealed …

AstraZeneca is embarking upon a joint venture that will involve the building of a new $125 million small-molecule plant in …

Healthcare strategic marketing consultancy Cello Health Consulting has appointed Robert Stringer as a senior consultant. Stringer takes 20 years’ marketing experience …

The Department of Health and the ABPI have confirmed a payment of £207 million from pharma to underwrite growth of …

Diabetes specialist firm Novo Nordisk has launched a new treatment in the UK which combines two of the Danish firm’s …
The added value of wearable devices

Not a week goes by without a big pharma merger story, and now it’s the turn of Dublin-headquartered Shire that …

US science and tech development and commercialisation firm Allied Minds has appointed Kevin Sharer to its board of directors. Sharer …

One year can make all the difference. The 2014 American Society of Clinical Oncology (ASCO) meeting took place just weeks …

NICE has published draft guidance for two prostate cancer drugs, recommending a Bayer medicine but rejecting one from Ferring Pharmaceuticals. …

Merck has launched the first new drug in a class of antibiotics in the UK in almost 15 years, becoming …

An FDA advisory panel has backed a new drug intended to boost female sex drive, but warned that it must …

Google is advancing a suite of applications known as ‘Study Kit’ that enable users to collect and share health information …

inVentiv Health has appointed Michael McKelvey as the president of its health clinical division and executive vice president. McKelvey is …

NICE has performed a U-turn on Janssen’s Stelara and has now recommended the drug for the treatment of psoriatic arthritis. …
Novartis has begun its court battle with Amgen over its biosimilar of cancer drug Neupogen, which Amgen is trying to …

The FDA is inching closer to a historic approval of a drug in the US commonly dubbed ‘Viagra for women’. …